PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:45 AM ET

Sponsor Check › Active Implants › Issuer

AI

Active Implants LLC

Limited Liability Company · organized in Delaware · formed more than five years before filing · Memphis, TN

Part of the sponsor group Active Implants (2 issuers, 13 filings) · linked by shared people, similar issuer names, director listed on many unrelated issuers (not used to group) · not the same sponsor?

$55.4Mreported sold (max)
59investors (max)
6offerings
8Form D filings
2013–2022filing years
0new, last 12 mo

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer Feb 7, 2022 · Courts (RECAP) last checked: Oct 24, 2026, 2:12 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Active Implants LLC is a limited liability company organized in Delaware (formed more than five years before filing), based in Memphis, TN, one of 2 issuers in the sponsor group Active Implants.

What this means This is one deal company run by a team with 2 companies on file. The group page shows the whole team's track record; this page is the one deal.

It has filed 8 Form D filings (6 originals, 2 amendments) for 6 offerings between Jun 2013 and Feb 2022. The latest filing of each offering reports a combined $131.9M sold of $205.5M offered to 141 investors; industry as reported: other health care; latest exemption Rule 506(b).

What this means A repeat filer — 6 separate raises over about 9 years. Amendments are routine updates (an ongoing raise must update its Form D at least once a year).

Key people as listed: Adam Klyce (executive officer), Charles W. Federico (director), Erik Harris (executive officer), Gary D. Henley (director), Henry Klyce (executive officer and director) and 13 more.

What this means These are the people the company itself named as running or promoting it. Tap a name to see every other deal they are on.

Reported money out: $19M of proceeds to officers, directors or promoters (latest filing per offering). No sales-compensation recipients are listed.

What this means $19M of investor money was reported as going to the people running the deal — about 14.4% of what was sold. The form does not say what for (fees, salaries, buying something from them); ask. No broker was paid — the sponsor sold it directly to investors.

Sister issuers in the group include Active Implants Corp.

Activity: 0 new offerings in the last 12 months; latest amendment Sep 23, 2020; latest filing Feb 7, 2022.

What this means No new raise filed in the past year — this deal company may be done raising, or simply quiet.

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Active Implants LLC.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — none found.

What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 8 public filings for Active Implants LLC and found 9 differences, 2 worth asking the sponsor about: 5 filings report more than 10% of the money raised going to insiders; Haynes Morris is no longer listed on the Oct 9, 2018 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

Business registration (state registry / Secretary of State)

State business registry (Secretary of State) 0 records matched to Active Implants LLC

No Secretary of State record matched in the registries searched (the issuer's reported state of incorporation, DE, has not been searched). Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); KY (Kentucky Secretary of State — Business Entity Search (sosbes.sos.ky.gov), searched by issuer name, data as of Oct 24, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

1 possible match is in human review and not shown.

What the community is saying

Community search for Active Implants LLC has not run yet — it is joining a line of 60,262 names; searches run around the clock at the hosts' allowed rate. Searched so far: 690 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:12 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Active Implants LLC..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:12 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this issuer has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this issuer yet.

9 differences found between the filings for Active Implants LLC — 2 worth asking about (compared 8 filings on Oct 24, 2026)

Worth asking · Mar 24, 2017 – Feb 7, 2022

5 filings report more than 10% of the money raised going to insiders

49% of the money raised went to insiders — Active Implants LLC · 42% of the money raised went to insiders — Active Implants LLC · 24% of the money raised went to insiders — Active Implants LLC · 15% of the money raised went to insiders — Active Implants LLC · 21% of the money raised went to insiders — Active Implants LLC

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Sources
Note · Jan 21, 2022 – Feb 7, 2022

Form D filed 17 days after the first sale — Active Implants LLC

The filing says the first sale was Jan 21, 2022. The Form D was filed Feb 7, 2022 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jun 10, 2013 – Feb 7, 2022

6 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Active Implants LLC (latest filing Feb 7, 2022) · No amendment in the last 12 months on an offering that may still be open — Active Implants LLC (latest filing Sep 23, 2020) · No amendment in the last 12 months on an offering that may still be open — Active Implants LLC (latest filing Oct 9, 2018) · No amendment in the last 12 months on an offering that may still be open — Active Implants LLC (latest filing Mar 24, 2017) · No amendment in the last 12 months on an offering that may still be open — Active Implants LLC (latest filing Sep 10, 2013) · and 1 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Worth asking · Feb 16, 2018 – Oct 9, 2018

Haynes Morris is no longer listed on the Oct 9, 2018 amendment — Active Implants LLC

Haynes Morris appears on the Feb 16, 2018 Form D (director) but not on the Oct 9, 2018 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Sep 23, 2020 – Feb 7, 2022

Ted Davis's role changed at Active Implants LLC: executive officer, director → director

The Sep 23, 2020 filing lists Ted Davis as executive officer, director; the Feb 7, 2022 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Jun 18, 2013 – Sep 10, 2013

Henry Klyce's role changed at Active Implants LLC: executive officer → executive officer, director

The Jun 18, 2013 filing lists Henry Klyce as executive officer; the Sep 10, 2013 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Feb 13, 2019 – Sep 23, 2020

Offering amount changed between filings — Active Implants LLC

The Feb 13, 2019 filing says $55,000,000 offered; the Sep 23, 2020 Form D/A says $75,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Feb 16, 2018 – Oct 9, 2018

Offering amount changed between filings — Active Implants LLC

The Feb 16, 2018 filing says $10,100,000 offered; the Oct 9, 2018 Form D/A says $14,100,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jun 18, 2013 – Mar 24, 2017

Reported revenue range changed between filings — Active Implants LLC

"No Revenues" (Jun 18, 2013); then "Decline to Disclose" (Mar 24, 2017).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 6 offerings report sales commissions; 0 report finder's fees; 5 report proceeds to related persons totalling $19,000,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Feb 7, 2022 D
File 021-432594
$0$0$1,300,000 (est.)None listed on this filingEDGAR ↗
Sep 23, 2020 D/A
File 021-332715
$0$0$8,500,000 (est.)None listed on this filingEDGAR ↗
Oct 9, 2018 D/A
File 021-305906
$0$0$2,500,000 (est.)None listed on this filingEDGAR ↗
Mar 24, 2017 D
File 021-283315
$0$0$4,200,000 (est.)None listed on this filingEDGAR ↗
Sep 10, 2013 D
File 021-202564
$0$0$2,500,000 (est.)None listed on this filingEDGAR ↗
Jun 18, 2013 D
File 021-198193
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Property records 0 documents · 0 ownership records · last checked Oct 24, 2026, 10:16 AM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to Active Implants LLC in the sources searched.

Not found in sources searched as of Oct 24, 2026, 10:16 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2005–2026) — 1,032,426 records, loaded Oct 24, 2026, 8:00 AM ET; Dallas County TX (DCAD ownership rolls 2021–2027) — 285,535 records, loaded Oct 24, 2026, 8:20 AM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll) — 514,336 records, loaded Oct 24, 2026, 8:25 AM ET; King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published) — 538,619 records, loaded Oct 24, 2026, 8:27 AM ET; Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026) — 1,263,035 records, loaded Oct 24, 2026, 9:34 AM ET. Still to be looked up for this issuer: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2005–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership rolls 2021–2027); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll); King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published); Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026); also looked up per issuer when its page is viewed. Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 8:30 AM ET; King County WA Assessor Real Property Sales extract (EXTR_RPSale.csv) Oct 24, 2026, 8:27 AM ET; Florida DOR NAL roll (Palm Beach 60) Oct 24, 2026, 8:25 AM ET; Florida DOR NAL roll (Broward 16) Oct 24, 2026, 8:24 AM ET; Florida DOR NAL roll (Dade 23) Oct 24, 2026, 8:23 AM ET; Florida DOR NAL roll (Hillsborough 39) Oct 24, 2026, 8:21 AM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 24, 2026, 8:20 AM ET; Harris County Appraisal District real_acct.txt Oct 24, 2026, 8:00 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Offerings (SEC Form D)

Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.

Offerings at a glance — 6 offerings, 8 filings (one row per SEC file number)
File no.Original Form DLatest filingAmendmentsOffered (latest)Sold (latest)Industry (latest)
021-432594Feb 7, 2022 EDGAR ↗Feb 7, 2022 D EDGAR ↗0$8,400,000$5,500,000Other Health Care
021-332715Feb 13, 2019 EDGAR ↗Sep 23, 2020 D/A EDGAR ↗1
latest Sep 23, 2020
$75,000,000$55,397,593Other Health Care
021-305906Feb 16, 2018 EDGAR ↗Oct 9, 2018 D/A EDGAR ↗1
latest Oct 9, 2018
$14,100,000$11,769,462Other Health Care
021-283315Mar 24, 2017 EDGAR ↗Mar 24, 2017 D EDGAR ↗0$40,000,000$10,000,000Other Health Care
021-202564Sep 10, 2013 EDGAR ↗Sep 10, 2013 D EDGAR ↗0$66,000,000$48,666,666Other Health Care
021-198193Jun 18, 2013 EDGAR ↗Jun 18, 2013 D EDGAR ↗0$2,000,000$600,000Other Health Care

Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.

Feb 7, 2022 D Other Health Care — $5,500,000 sold of $8,400,000 · 6 investors EDGAR ↗
FilingForm D filed Feb 7, 2022
SEC file no. 021-432594 · accession 0001579434-22-000001
Raise progress$5,500,000 sold of $8,400,000 offered (65%) · $2,900,000 remaining · first sale Jan 21, 2022
Filing timingDate of first sale: Jan 21, 2022 · Form D filed: Feb 7, 2022 (17 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale1,738 days (4.8 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors6 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredDebt; Option, warrant or other right to acquire; Security to be acquired upon exercise
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $1,300,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Feb 7, 2022)
Market contextMinimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $8,400,000. Typical range: $829,831–$9,999,998.
Investors: 6. Typical range: 2–15.
"Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Sep 23, 2020 D/A Other Health Care — $55,397,593 sold of $75,000,000 · 59 investors EDGAR ↗
FilingForm D/A (amendment) filed Sep 23, 2020 · amends 0001579434-19-000001 ↗
SEC file no. 021-332715 · accession 0001579434-20-000001 · filing 2 of 2 in this offering
Raise progress$55,397,593 sold of $75,000,000 offered (74%) · $19,602,407 remaining · first sale Jan 29, 2019
Filing timingDate of first sale: Jan 29, 2019 · Original Form D filed: Feb 13, 2019 (15 days after first sale) · This amendment (Form D/A) filed: Sep 23, 2020
This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn.
Time since first sale2,826 days (7.7 years)
Annual amendmentsIssuer reported the offering may last more than one year. This filing is an amendment dated Sep 23, 2020. Most recent amendment for this offering in our index: this filing, Sep 23, 2020.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors59 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredDebt; Option, warrant or other right to acquire; Security to be acquired upon exercise
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $8,500,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Sep 23, 2020)
Changes vs previous filing
  • total sold: $36,784,362 (Feb 13, 2019) → $55,397,593 (Sep 23, 2020)
  • total offering: $55,000,000 (Feb 13, 2019) → $75,000,000 (Sep 23, 2020)
  • remaining: $18,215,638 (Feb 13, 2019) → $19,602,407 (Sep 23, 2020)
  • investors: 43 (Feb 13, 2019) → 59 (Sep 23, 2020)
  • proceeds to insiders: $1,800,000 (Feb 13, 2019) → $8,500,000 (Sep 23, 2020)
  • related persons added (Sep 23, 2020): Ryan Belaney
Compared with the D filed Feb 13, 2019 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn.
Market contextMinimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $75,000,000. Typical range: $829,831–$9,999,998.
Investors: 59. Typical range: 2–15.
"Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Feb 13, 2019 D Other Health Care — $36,784,362 sold of $55,000,000 · 43 investors EDGAR ↗
FilingForm D filed Feb 13, 2019
SEC file no. 021-332715 · accession 0001579434-19-000001 · filing 1 of 2 in this offering
Raise progress$36,784,362 sold of $55,000,000 offered (67%) · $18,215,638 remaining · first sale Jan 29, 2019
Filing timingDate of first sale: Jan 29, 2019 · Form D filed: Feb 13, 2019 (15 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale2,826 days (7.7 years)
Annual amendmentsIssuer reported the offering may last more than one year. Most recent amendment for this offering in our index: Sep 23, 2020 (EDGAR ↗).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors43 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredDebt; Option, warrant or other right to acquire; Security to be acquired upon exercise
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $1,800,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Feb 12, 2019)
Market contextMinimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $55,000,000. Typical range: $829,831–$9,999,998.
Investors: 43. Typical range: 2–15.
"Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Oct 9, 2018 D/A Other Health Care — $11,769,462 sold of $14,100,000 · 26 investors EDGAR ↗
FilingForm D/A (amendment) filed Oct 9, 2018 · amends 0001393725-18-000005 ↗
SEC file no. 021-305906 · accession 0001579434-18-000002 · filing 2 of 2 in this offering
Raise progress$11,769,462 sold of $14,100,000 offered (83%) · $2,330,538 remaining · first sale Feb 6, 2018
Filing timingDate of first sale: Feb 6, 2018 · Original Form D filed: Feb 16, 2018 (10 days after first sale) · This amendment (Form D/A) filed: Oct 9, 2018
This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn.
Time since first sale3,183 days (8.7 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. This filing is an amendment dated Oct 9, 2018. Most recent amendment for this offering in our index: this filing, Oct 9, 2018.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors26 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredDebt
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $2,500,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Oct 9, 2018)
Changes vs previous filing
  • total sold: $3,287,114 (Feb 16, 2018) → $11,769,462 (Oct 9, 2018)
  • total offering: $10,100,000 (Feb 16, 2018) → $14,100,000 (Oct 9, 2018)
  • remaining: $6,812,886 (Feb 16, 2018) → $2,330,538 (Oct 9, 2018)
  • investors: 11 (Feb 16, 2018) → 26 (Oct 9, 2018)
  • proceeds to insiders: $1,600,000 (Feb 16, 2018) → $2,500,000 (Oct 9, 2018)
  • related persons added (Oct 9, 2018): Tim Rinks, William Robinson
  • related persons no longer listed (Oct 9, 2018): Haynes Morris
Compared with the D filed Feb 16, 2018 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn.
Market contextMinimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $14,100,000. Typical range: $829,831–$9,999,998.
Investors: 26. Typical range: 2–15.
"Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Feb 16, 2018 D Other Health Care — $3,287,114 sold of $10,100,000 · 11 investors EDGAR ↗
FilingForm D filed Feb 16, 2018
SEC file no. 021-305906 · accession 0001393725-18-000005 · filing 1 of 2 in this offering
Raise progress$3,287,114 sold of $10,100,000 offered (33%) · $6,812,886 remaining · first sale Feb 6, 2018
Filing timingDate of first sale: Feb 6, 2018 · Form D filed: Feb 16, 2018 (10 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale3,183 days (8.7 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Oct 9, 2018 (EDGAR ↗).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors11 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredDebt
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $1,600,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Feb 16, 2018)
Market contextMinimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $10,100,000. Typical range: $829,831–$9,999,998.
Investors: 11. Typical range: 2–15.
"Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Mar 24, 2017 D Other Health Care — $10,000,000 sold of $40,000,000 · 1 investors EDGAR ↗
FilingForm D filed Mar 24, 2017
SEC file no. 021-283315 · accession 0001393725-17-000065
Raise progress$10,000,000 sold of $40,000,000 offered (25%) · $30,000,000 remaining · first sale Mar 15, 2017
Filing timingDate of first sale: Mar 15, 2017 · Form D filed: Mar 24, 2017 (9 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale3,511 days (9.6 years)
Annual amendmentsIssuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors1 total · issuer reported no non-accredited investors
Exemption claimedRule 506(b) — no general advertising; up to 35 non-accredited investors allowed
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $4,200,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Mar 24, 2017)
Market contextMinimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $40,000,000. Typical range: $829,831–$9,999,998.
Investors: 1. Typical range: 2–15.
"Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Sep 10, 2013 D Other Health Care — $48,666,666 sold of $66,000,000 · 40 investors EDGAR ↗
FilingForm D filed Sep 10, 2013
SEC file no. 021-202564 · accession 0001579434-13-000002
Raise progress$48,666,666 sold of $66,000,000 offered (74%) · $17,333,334 remaining · first sale Aug 28, 2013
Filing timingDate of first sale: Aug 28, 2013 · Form D filed: Sep 10, 2013 (13 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale4,806 days (13.2 years)
Annual amendmentsIssuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors40 total · includes 2 non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $2,500,000 (est.)
Signed byJ. Michael Keenan, Chief Financial Officer (Sep 9, 2013)
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Jun 18, 2013 D Other Health Care — $600,000 sold of $2,000,000 · 9 investors EDGAR ↗
FilingForm D filed Jun 18, 2013
SEC file no. 021-198193 · accession 0001579434-13-000001
Raise progress$600,000 sold of $2,000,000 offered (30%) · $1,400,000 remaining · first sale Jun 10, 2013
Filing timingDate of first sale: Jun 10, 2013 · Form D filed: Jun 18, 2013 (8 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale4,885 days (13.4 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors9 total · issuer reported no non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredDebt; Option, warrant or other right to acquire
Entity detailsOrganized in DELAWARE · formed more than five years before filing · revenue range: No Revenues (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther Health Care
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byJ. Michael Keenan, CFO of Manager of Issuer (Jun 13, 2013)
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Amendment history — 2 amendments on this page, each compared with the filing before it in the same offering
Amendment filedFile no.Compared withWhat changed (both values as filed)
Sep 23, 2020 EDGAR ↗021-332715Feb 13, 2019 Dtotal sold: $36,784,362 (Feb 13, 2019) → $55,397,593 (Sep 23, 2020) · total offering: $55,000,000 (Feb 13, 2019) → $75,000,000 (Sep 23, 2020) · remaining: $18,215,638 (Feb 13, 2019) → $19,602,407 (Sep 23, 2020) · and 3 more (open the filing above)
Oct 9, 2018 EDGAR ↗021-305906Feb 16, 2018 Dtotal sold: $3,287,114 (Feb 16, 2018) → $11,769,462 (Oct 9, 2018) · total offering: $10,100,000 (Feb 16, 2018) → $14,100,000 (Oct 9, 2018) · remaining: $6,812,886 (Feb 16, 2018) → $2,330,538 (Oct 9, 2018) · and 4 more (open the filing above)

Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.

All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Feb 7, 2022. Industry as reported, by offering: All 6 offerings reported: Other Health Care (2013–2022).

Key people 17

Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.

NameRelationshipAddress stateOn filings (first → last)Also listed on
AK Adam KlyceExecutive OfficerTNMar 24, 2017 → Feb 7, 2022
on 6 of 8 filings
listed on the latest filing
—
CF Charles W. FedericoDirector
Issuer's note: Member of the Board of Managers of the Issuer
TNFeb 16, 2018 → Feb 7, 2022
on 5 of 8 filings
listed on the latest filing
—
EH Erik HarrisExecutive OfficerTNFeb 16, 2018 → Feb 7, 2022
on 5 of 8 filings
listed on the latest filing
—
GH Gary D. HenleyDirector
Issuer's note: Member of the Board of Managers of the Issuer
TNFeb 16, 2018 → Feb 7, 2022
on 5 of 8 filings
listed on the latest filing
—
HK Henry KlyceExecutive Officer, Director
Issuer's note: Executive Chairman and Member of the Board of Managers of the Issuer
TNJun 18, 2013 → Feb 7, 2022
on 8 of 8 filings
listed on the latest filing
1 other issuer
JK J. Michael Keenan
also filed as J Michael Keenan
Executive Officer
Issuer's note: Executive Officer of Manager of Issuer
TNJun 18, 2013 → Feb 7, 2022
on 8 of 8 filings
listed on the latest filing
—
JL James D. LackieDirector
Issuer's note: Member of the Board of Managers of the Issuer
TNSep 10, 2013 → Feb 7, 2022
on 7 of 8 filings
listed on the latest filing
10 other issuers
RB Ryan BelaneyExecutive OfficerTNSep 23, 2020 → Feb 7, 2022
on 2 of 8 filings
listed on the latest filing
—
SW Spence Wilson, Jr.
person page: Spence L. Wilson
Director
Issuer's note: Member of the Board of Managers of the Issuer
TNSep 10, 2013 → Feb 7, 2022
on 7 of 8 filings
listed on the latest filing
15 other issuers
TD Ted DavisExecutive Officer, Director
Issuer's note: Member of the Board of Managers of the Issuer
TNMar 24, 2017 → Feb 7, 2022
on 6 of 8 filings
listed on the latest filing
—
TR Tim RinksExecutive OfficerTNOct 9, 2018 → Feb 7, 2022
on 4 of 8 filings
listed on the latest filing
—
WR William RobinsonDirector
Issuer's note: Member of the Board of Managers of the Issuer
TNOct 9, 2018 → Feb 7, 2022
on 4 of 8 filings
listed on the latest filing
—
WM William T. Mays, Jr.Director
Issuer's note: Member of the Board of Managers of the Issuer
TNSep 10, 2013 → Feb 7, 2022
on 7 of 8 filings
listed on the latest filing
1 other issuer
RT Richard TreharneExecutive Officer
Issuer's note: Executive Officer of Manager of Issuer
TNJun 18, 2013 → Sep 23, 2020
on 7 of 8 filings
not listed on the latest filing (Feb 7, 2022)
3 other issuers
HM Haynes MorrisDirector
Issuer's note: Member of the Board of Managers of the Issuer
TNSep 10, 2013 → Feb 16, 2018
on 3 of 8 filings
not listed on the latest filing (Feb 7, 2022)
—
CI Corporation Active ImplantsPromoter
Issuer's note: Manager and Member of the Issuer
TNJun 18, 2013 → Sep 10, 2013
on 2 of 8 filings
not listed on the latest filing (Feb 7, 2022)
—
LG Lex GiltaijExecutive Officer
Issuer's note: Executive Officer of Manager of Issuer
TNJun 18, 2013 → Sep 10, 2013
on 2 of 8 filings
not listed on the latest filing (Feb 7, 2022)
—

Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (Adam T. Klyce; Erik W. Harris; Henry Michael Klyce; Ryan W. Belaney; Spence T. Wilson, Jr.; Tim W. Rinks; William W. Robinson; Richard Michael Treharne; Haynes T. Morris) — the filing on EDGAR is the source.

Connections

Other issuers listing the same people:

Shared address: this business address appears on filings for 3 other issuers. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Active Implants LLC.

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for Active Implants LLC as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Public profiles

Public profiles official links and public statements, each with its source and date

No website or social profile named in Active Implants LLC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #165,769 of 374,652 in line (1,386 issuers searched so far).

Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.

Entity standing: not checked (no official programmatic source for TN yet).

Export this report as PDF (all source links + data timestamp) · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Corrections log

No corrections have been requested for this page.

Filing-to-filing changes are in Amendment history above.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Claim this profile · Facts policy

Email me the full report

The complete public-record profile for Active Implants LLC, plus the weekly new-filings list.

What do you want to do?

Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.

Request a correction

Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).

Sponsor response

Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.

Claim this profile (sponsors)

Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Memphis, TN). Each opens in a new tab; what you find there is not verified by PartnerFacts.